other material
confidence high
sentiment neutral
materiality 0.15
Serina Therapeutics eliminates Series A Preferred stock designation after all shares convert to common
Serina Therapeutics, Inc.
- Certificate of Elimination filed with Delaware Secretary of State on October 5, 2026, removing all Series A Convertible Preferred terms from the charter.
- Series A Certificate of Designations originally filed April 10, 2025, and corrected May 22, 2025; no Series A Preferred shares remain outstanding.
- All issued Series A Preferred converted into common stock, and none will be issued; eliminated shares revert to authorized but unissued undesignated preferred stock.